Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome
- 1 May 2023
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 85 (1), 3-7
- https://doi.org/10.1016/j.eururo.2023.04.015
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Testosterone and insulin resistance in the metabolic syndrome and T2DM in menNature Reviews Endocrinology, 2013
- Use of β‐blockers is associated with prostate cancer‐specific survival in prostate cancer patients on androgen deprivation therapyThe Prostate, 2012
- Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancerProstate Cancer and Prostatic Diseases, 2012
- Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-AnalysisJournal of Clinical Endocrinology & Metabolism, 2011
- Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancerCritical Reviews in Oncology/Hematology, 2010
- Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortalityCancer, 2007
- Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition CohortCancer Epidemiology, Biomarkers & Prevention, 2007
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate CancerJournal of Clinical Oncology, 2006
- Metabolic Syndrome in Men With Prostate Cancer Undergoing Long-Term Androgen-Deprivation TherapyJournal of Clinical Oncology, 2006
- Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy MenJournal of Clinical Endocrinology & Metabolism, 2001